Bromodomain Inhibitor Set

Biochemicals - Small Molecule Inhibitors

Cat No: 28315

Biochemicals - Small Molecule Inhibitors

The Bromodomain Inhibitor Set consists of approximately 35 selective and non-selective bromodomain inhibitors and negative controls. This set contains bromodomain inhibitors targeting members of the bromodomain and extra-terminal domain (BET) and brom...

This product can only be bought through Cayman Chemical. Please contact us.

Product Overview
Data
Downloads
About Cayman

Territorial Availability: Available through Bertin Technologies only in France

Correlated keywords:

nonselective extraterminal EP 300 BRD 9 7 TAF 1 SGC structural genomics consortium ABBV075 AZD5153 BAY299 BAY364 BAZ2ICR BI7273 BI9564 CeMMEC 1 13 CPI203 CPI637 gSK 2801 5959 6853 IBET151 IBET726 IBRD9 JQ ICBP112 Lin281632 LP 99 NI57 OF1 OTX 015 PFCBP1 PFI1 PFI3 PFI4 SGCCBP30 TP472 TP472N UMB32 XMD892

Product Overview:
The Bromodomain Inhibitor Set consists of approximately 35 selective and non-selective bromodomain inhibitors and negative controls. This set contains bromodomain inhibitors targeting members of the bromodomain and extra-terminal domain (BET) and bromodomain and plant homeodomain finger-containing (BRPF) families, CBP/CREBBP and p300, BRD9 and BRD7, and TAF1, among others. Please review the product insert for a full list of targets.

Size	1 ea
Shipping	dry ice
Custom Code	3822.19
UNSPSC code	41116107

Technical File

MSDS

Click here to ask for your quote and get 15% off Cayman's products.

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.

/ We also advise you

Cross selling for this product : Bromodomain Inhibitor Set There are 2 products.